Imunon’s IL-12 gene therapy IMImuNN-001 converts the tumour microenvironment from “cold” to “hot” by both, halting immunosuppressive makers, and stimulating…
Artificial intelligence (AI) is expected to not only supplement clinical trials, but redefine the sector, while the industry braces for…
Regulatory overhaul, international trade tariffs, and the burgeoning disruption imposed by artificial intelligence (AI) are moving the clinical trials industry…
Tariffs imposed by President Trump on US pharma imports have left experts charting a new course for the nation’s clinical…
“Japan has the second biggest market for branded drugs and is the third largest market for pharmaceuticals overall,” says Kento…
An analysis of clinical trial registries, including ClinicalTrials.gov and Australian and New Zealand registries, has shown a 20% reduction in…
Artificial intelligence (AI) is revolutionising clinical trials, offering ways to improve the consent process, but concerns regarding the complete reliability…
While encouraged by revised regulations aimed at boosting UK clinical studies, experts say busy schedules of NHS workers present a…
Against the backdrop of the recent US Food and Drug Administration’s (FDA) staff cuts and administrative realignment, understanding accelerated approval…
Is the clinical trials field doing enough to centre the needs and concerns of patients in research? That was the…
